Preliminary Study on the Diagnostic Value Comparison of 18F-FAPI-04 PET/CT and PET/MR in Gastric Cancer
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: The clinical value of 18F-FAPI-04 PET/CT and PET/MR imaging in the diagnosis and staging of gastric cancer.
- Who it may be relevant to
- Registry conditions: Gastric Cancer. Basic parameters: 18 years — 90 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- China
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Overview
This project aims to comprehensively analyze the diagnostic efficacy of SUVmax, SUVean, TLG, MTV, etc. in gastric cancer through 18F-FAPI-04 PET/CT imaging combined with serum tumor markers and other methods, and construct a molecular imaging diagnostic model for gastric cancer; Next, analyze the diagnostic efficacy of 18F-FAPI-04 PET/CT and PET/MR multimodal imaging in evaluating SUVmax, PET/CT-PCI, and PET/MR-PCI for gastric cancer peritoneal metastasis, and construct a molecular imaging diagnostic model for gastric cancer peritoneal metastasis; Exploring the clinical value of 18F-FAPI-04 PET/CT and PET/MR imaging in the diagnosis and staging of gastric cancer.
Interventions
- Diagnostic test The clinical value of 18F-FAPI-04 PET/CT and PET/MR imaging in the diagnosis and staging of gastric cancer
The clinical value of 18F-FAPI-04 PET/CT and PET/MR imaging in the diagnosis and staging of gastric cancer
Primary outcome measures
- 18F-FAPI-04 PET imaging diagnosis of gastric cancer detection rate [Time frame: 2 years]
Secondary outcome measures (1)
- Detection rate of peritoneal metastasis in gastric cancer [Time frame: 2 years]
Eligibility criteria
Inclusion criteria
- Age over 18 years old;
- Diagnosed as a patient with gastric cancer;
- Receive FAPI PET/CT and FDG PET/CT imaging within one week;
- Perform serum tumor marker testing one week before and after scanning
Exclusion criteria
- History of other malignant tumors;
- Patients with severe infections, severe underlying diseases such as heart, kidney, and liver;
- Patients with contraindications for PET-CT examination, poor physical condition, and inability to tolerate the examination;
- Patients with unorganized pathology or incomplete clinical data
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Observational model
- Cohort
Study locations
China · 1 center
- Hunan Cancer hospital — Changsha
Identifiers
NCT: NCT06543108 · FAPI-001